Estimating disease severity of Omicron and Delta SARS-CoV-2 infections

The Omicron variant of SARS-CoV-2 has been reported to cause milder disease in adults but lead to increased hospital admissions in children. How can we compare disease severity in Omicron and Delta infections, and how should differences be interpreted?

Detalles Bibliográficos
Autores principales: Sigal, Alex, Milo, Ron, Jassat, Waasila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002222/
https://www.ncbi.nlm.nih.gov/pubmed/35414124
http://dx.doi.org/10.1038/s41577-022-00720-5
_version_ 1784685846482386944
author Sigal, Alex
Milo, Ron
Jassat, Waasila
author_facet Sigal, Alex
Milo, Ron
Jassat, Waasila
author_sort Sigal, Alex
collection PubMed
description The Omicron variant of SARS-CoV-2 has been reported to cause milder disease in adults but lead to increased hospital admissions in children. How can we compare disease severity in Omicron and Delta infections, and how should differences be interpreted?
format Online
Article
Text
id pubmed-9002222
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90022222022-04-12 Estimating disease severity of Omicron and Delta SARS-CoV-2 infections Sigal, Alex Milo, Ron Jassat, Waasila Nat Rev Immunol Comment The Omicron variant of SARS-CoV-2 has been reported to cause milder disease in adults but lead to increased hospital admissions in children. How can we compare disease severity in Omicron and Delta infections, and how should differences be interpreted? Nature Publishing Group UK 2022-04-12 2022 /pmc/articles/PMC9002222/ /pubmed/35414124 http://dx.doi.org/10.1038/s41577-022-00720-5 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Sigal, Alex
Milo, Ron
Jassat, Waasila
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title_full Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title_fullStr Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title_full_unstemmed Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title_short Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
title_sort estimating disease severity of omicron and delta sars-cov-2 infections
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002222/
https://www.ncbi.nlm.nih.gov/pubmed/35414124
http://dx.doi.org/10.1038/s41577-022-00720-5
work_keys_str_mv AT sigalalex estimatingdiseaseseverityofomicronanddeltasarscov2infections
AT miloron estimatingdiseaseseverityofomicronanddeltasarscov2infections
AT jassatwaasila estimatingdiseaseseverityofomicronanddeltasarscov2infections

Ejemplares similares